Ameriprise’s Marvell Technology MRVL Stock Holding History

Ameriprise’s Portfolio MRVL Stock Details MRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.44M	Buy	+14,900	New	+$2.99M	﹤0.01%	2625

Other funds holding MRVL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ameriprise's MRVL Position: Q2 2026 in Review

Ameriprise reduced its Marvell Technology (MRVL) stake by 56% in Q2 2026, selling an estimated $2.36B and leaving 9,096,728 shares worth $2.71B. The position accounts for 0.55% of the portfolio, ranked #26.

Ameriprise first reported a position in MRVL in Q2 2013 and has held it in 53 quarters since. 2,213 funds tracked by Wall St. Rank hold MRVL as of Q2 2026.

Ameriprise held 9,096,728 shares of Marvell Technology worth $2.71B as of Q2 2026.
Ameriprise sold 11,747,911 Marvell Technology shares in Q2 2026, an estimated $2.36B.
Marvell Technology made up 0.55% of Ameriprise's portfolio in Q2 2026, its #26 holding.
Ameriprise first reported a position in Marvell Technology in Q2 2013 and has held it in 53 quarters since.
2,213 funds tracked by Wall St. Rank held Marvell Technology as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.